Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Debt Ratio: 2016-2025

Historic Debt Ratio for Myriad Genetics (MYGN) over the last 7 years, with Sep 2025 value amounting to 0.16.

  • Myriad Genetics' Debt Ratio rose 355.05% to 0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16, marking a year-over-year increase of 355.05%. This contributed to the annual value of 0.04 for FY2024, which is 14.76% up from last year.
  • Latest data reveals that Myriad Genetics reported Debt Ratio of 0.16 as of Q3 2025, which was up 87.14% from 0.09 recorded in Q2 2025.
  • Myriad Genetics' Debt Ratio's 5-year high stood at 0.16 during Q3 2025, with a 5-year trough of 0.03 in Q2 2023.
  • In the last 3 years, Myriad Genetics' Debt Ratio had a median value of 0.04 in 2024 and averaged 0.06.
  • Data for Myriad Genetics' Debt Ratio shows a peak YoY skyrocketed of 3,367.42% (in 2021) over the last 5 years.
  • Myriad Genetics' Debt Ratio (Quarterly) stood at 0.08 in 2021, then reached 0.03 in 2023, then climbed by 14.76% to 0.04 in 2024, then skyrocketed by 355.05% to 0.16 in 2025.
  • Its Debt Ratio stands at 0.16 for Q3 2025, versus 0.09 for Q2 2025 and 0.06 for Q1 2025.